Section 503A of the Federal Food, Drug, and Cosmetic Act governs state-licensed pharmacies and physicians preparing medications for identified individual patients
Some individuals may continue experiencing appetite-related effects during this period
Warning Letters (Warning Letters Database) Drug manufacturers, supplement companies, and medical device makers may receive a Warning Letter from the FDA if they commit serious violations of federal regulations
Novel 5,6-diphenyl-1,2,4-triazine-3-thiol derivatives as dual COX-2/5-LOX inhibitors devoid of cardiotoxicity
The role of the inflammatory foam cells (so-called because theyre so packed with cholesterol they look foamy under a microscope) affected by TMAO is explained in my video series that begins with Arterial Acne, and continues in Blocking the First Step of Heart Disease
Patients with persistent tinnitus conditions may require treatments such as cognitive-behavioral therapy or medication